{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:22:40Z","timestamp":1783563760627,"version":"3.55.0"},"reference-count":57,"publisher":"Impact Journals, LLC","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2022,8,15]]},"DOI":"10.18632\/aging.204206","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T16:55:53Z","timestamp":1660236953000},"page":"6066-6080","source":"Crossref","is-referenced-by-count":11,"title":["PDCD10 promotes the aggressive behaviors of pituitary adenomas by up-regulating CXCR2 and activating downstream AKT\/ERK signaling"],"prefix":"10.18632","volume":"14","author":[{"given":"Jingdian","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"You","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg Walter","family":"Bartsch","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Marburg, Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongquan","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqiu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.beem.2009.05.008","article-title":"The epidemiology and genetics of pituitary adenomas.","volume":"2","author":"Beckers","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2","first-page":"110","article-title":"Clinical aspects of molecular biology of pituitary adenomas.","volume":"5","author":"Rudnik","year":"2012","journal-title":"Folia Neuropathol"},{"key":"3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1365-2265.2012.04381.x","article-title":"Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment.","volume":"7","author":"Brue","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3803\/EnM.2017.32.2.162","article-title":"Recent Progress in the Medical Therapy of Pituitary Tumors.","volume":"3","author":"Fleseriu","year":"2017","journal-title":"Endocrinol Metab (Seoul)"},{"key":"5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3171\/JNS\/2008\/108\/3\/0525","article-title":"Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence.","volume":"10","author":"Giovanelli","year":"2008","journal-title":"J Neurosurg"},{"key":"6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.surneu.2007.05.057","article-title":"Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.","volume":"6","author":"Delfini","year":"2007","journal-title":"Surg Neurol"},{"key":"7","doi-asserted-by":"publisher","first-page":"dgz211","DOI":"10.1210\/clinem\/dgz211","article-title":"Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas-A German Survey.","volume":"10","author":"Johanssen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11060-015-1991-y","article-title":"Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas.","volume":"12","author":"Scaroni","year":"2016","journal-title":"J Neurooncol"},{"key":"9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.modgep.2005.11.001","article-title":"Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development.","volume":"6","author":"Tournier-Lasserve","year":"2006","journal-title":"Gene Expr Patterns"},{"key":"10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2004.01.004","article-title":"Sensitive genetic biomarkers for determining apoptosis in the brown bullhead (Ameiurus nebulosus).","volume":"32","author":"Hubberstey","year":"2004","journal-title":"Gene"},{"key":"11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/BF03183610","article-title":"cDNA cloning and expression of an apoptosis-related gene, humanTFAR15 gene.","volume":"4","author":"Ma","year":"1999","journal-title":"Sci China C Life Sci"},{"key":"12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.biocel.2013.11.021","article-title":"STRIPAK complexes: structure, biological function, and involvement in human diseases.","volume":"4","author":"Pallas","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/ncb3083","article-title":"STRIPAK components determine mode of cancer cell migration and metastasis.","volume":"1","author":"Sahai","year":"2015","journal-title":"Nat Cell Biol"},{"key":"14","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1091\/mbc.e06-07-0608","article-title":"PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway.","volume":"1","author":"Ma","year":"2007","journal-title":"Mol Biol Cell"},{"key":"15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/426952","article-title":"Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations.","volume":"7","author":"Moreau","year":"2005","journal-title":"Am J Hum Genet"},{"key":"16","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1021\/pr0704276","article-title":"Proteomic identification of the cerebral cavernous malformation signaling complex.","volume":"6","author":"Wu","year":"2007","journal-title":"J Proteome Res"},{"key":"17","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.7150\/thno.43198","article-title":"Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10.","volume":"1","author":"Yin","year":"2020","journal-title":"Theranostics"},{"key":"18","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3389\/fonc.2020.01377","article-title":"PDCD10-Deficiency Promotes Malignant Behaviors and Tumor Growth via Triggering EphB4 Kinase Activity in Glioblastoma.","volume":"1","author":"Zhu","year":"2020","journal-title":"Front Oncol"},{"key":"19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3727\/096504017X15000757094686","article-title":"miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.","volume":"2","author":"Xu","year":"2018","journal-title":"Oncol Res"},{"key":"20","doi-asserted-by":"publisher","first-page":"e3000051","DOI":"10.1371\/journal.pbio.3000051","article-title":"TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10.","volume":"1","author":"Zhou","year":"2018","journal-title":"PLoS Biol"},{"key":"21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/s41419-021-04139-z","article-title":"Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated YAP activation.","volume":"1","author":"Yang","year":"2021","journal-title":"Cell Death Dis"},{"key":"22","first-page":"95","article-title":"Chemokines and chemokine receptors: their manifold roles in homeostasis and disease.","volume":"1","author":"Wang","year":"2004","journal-title":"Cell Mol Immunol"},{"key":"23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.5858\/2000-124-0520-EOTCRC","article-title":"Expression of the chemokine receptor CXCR2 in normal and neoplastic neuroendocrine cells.","volume":"12","author":"Peiper","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1517\/14728222.2013.772137","article-title":"CXCR2: a target for pancreatic cancer treatment?","volume":"1","author":"Hines","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"25","doi-asserted-by":"publisher","first-page":"637053","DOI":"10.3389\/fimmu.2021.637053","article-title":"Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia\/Macrophages Recruitment in Glioblastoma.","volume":"1","author":"Lei","year":"2021","journal-title":"Front Immunol"},{"key":"26","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1227\/00006123-199310000-00008","article-title":"Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings.","volume":"3","author":"Matula","year":"1993","journal-title":"Neurosurgery"},{"key":"27","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1073\/pnas.48.7.1184","article-title":"Hormone-producing cultures of adrenal and pituitary tumor origin.","volume":"4","author":"Cohen","year":"1962","journal-title":"Proc Natl Acad Sci USA"},{"key":"28","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1210\/endo.131.6.1446645","article-title":"Establishment of a folliculo-stellate-like cell line from a murine thyrotropic pituitary tumor.","volume":"13","author":"Ito","year":"1992","journal-title":"Endocrinology"},{"key":"29","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/ijc.30173","article-title":"Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.","volume":"13","author":"Carl","year":"2016","journal-title":"Int J Cancer"},{"key":"30","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1210\/jc.2017-00773","article-title":"Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification.","volume":"10","author":"Trouillas","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"31","doi-asserted-by":"publisher","first-page":"11556","DOI":"10.1074\/jbc.M111.320259","article-title":"Adaptor protein cerebral cavernous malformation 3 (CCM3) mediates phosphorylation of the cytoskeletal proteins ezrin\/radixin\/moesin by mammalian Ste20-4 to protect cells from oxidative stress.","volume":"28","author":"Zalvide","year":"2012","journal-title":"J Biol Chem"},{"key":"32","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1039\/c3mb70199a","article-title":"Role of cytoskeletal proteins in cerebral cavernous malformation signaling pathways: a proteomic analysis.","volume":"1","author":"Bencharit","year":"2014","journal-title":"Mol Biosyst"},{"key":"33","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1242\/dev.093526","article-title":"Ccm3, a gene associated with cerebral cavernous malformations, is required for neuronal migration.","volume":"14","author":"G\u00fcnel","year":"2014","journal-title":"Development"},{"key":"34","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1600-0463.2010.02669.x","article-title":"Programmed cell death-10 enhances proliferation and protects malignant T cells from apoptosis.","volume":"11","author":"Odum","year":"2010","journal-title":"APMIS"},{"key":"35","doi-asserted-by":"publisher","first-page":"101013","DOI":"10.1016\/j.tranon.2021.101013","article-title":"Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer.","volume":"1","author":"Venturella","year":"2021","journal-title":"Transl Oncol"},{"key":"36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1186\/s12885-015-1655-5","article-title":"Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.","volume":"1","author":"Sun","year":"2015","journal-title":"BMC Cancer"},{"key":"37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1089\/cbr.2019.3490","article-title":"CircSMARCA5 Facilitates the Progression of Prostate Cancer Through miR-432\/PDCD10 Axis.","volume":"3","author":"Wang","year":"2021","journal-title":"Cancer Biother Radiopharm"},{"key":"38","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.3892\/or.2018.6734","article-title":"miRNA-26a-5p and miR-26b-5p inhibit the proliferation of bladder cancer cells by regulating PDCD10.","volume":"4","author":"Liu","year":"2018","journal-title":"Oncol Rep"},{"key":"39","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT Transition States during Tumor Progression and Metastasis.","volume":"2","author":"Blanpain","year":"2019","journal-title":"Trends Cell Biol"},{"key":"40","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12967-019-2088-8","article-title":"CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial-mesenchymal transition.","volume":"1","author":"Zhao","year":"2019","journal-title":"J Transl Med"},{"key":"41","first-page":"2635","article-title":"Epithelial-mesenchymal Transition (EMT) Markers in Human Pituitary Adenomas Indicate a Clinical Course.","volume":"3","author":"Jiang","year":"2015","journal-title":"Anticancer Res"},{"key":"42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.bbcan.2019.01.005","article-title":"Potential roles and targeted therapy of the CXCLs\/CXCR2 axis in cancer and inflammatory diseases.","volume":"187","author":"Wei","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41586-020-2492-5","article-title":"Structural basis of CXC chemokine receptor 2 activation and signalling.","volume":"58","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"44","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1158\/0008-5472.CAN-12-0263","article-title":"CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma.","volume":"7","author":"Behrens","year":"2013","journal-title":"Cancer Res"},{"key":"45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.canlet.2017.09.030","article-title":"CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2.","volume":"41","author":"Yang","year":"2018","journal-title":"Cancer Lett"},{"key":"46","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1158\/1535-7163.MCT-12-0529","article-title":"Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis.","volume":"1","author":"Singh","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"47","doi-asserted-by":"publisher","first-page":"7079","DOI":"10.1158\/0008-5472.CAN-13-1355","article-title":"Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche.","volume":"7","author":"Fischbach","year":"2013","journal-title":"Cancer Res"},{"key":"48","doi-asserted-by":"publisher","first-page":"e3077","DOI":"10.1371\/journal.pone.0003077","article-title":"Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties.","volume":"3","author":"Lokshin","year":"2008","journal-title":"PLoS One"},{"key":"49","doi-asserted-by":"publisher","first-page":"R331","DOI":"10.1530\/ERC-14-0188","article-title":"The PI3K\/AKT\/mTOR pathway in the pathophysiology and treatment of pituitary adenomas.","volume":"2","author":"Zadeh","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"50","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ejca.2011.11.002","article-title":"Targeting Raf\/MEK\/ERK pathway in pituitary adenomas.","volume":"4","author":"Ting","year":"2012","journal-title":"Eur J Cancer"},{"key":"51","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nm.4169","article-title":"Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation.","volume":"2","author":"Yan","year":"2016","journal-title":"Nat Med"},{"key":"52","doi-asserted-by":"publisher","first-page":"e142838","DOI":"10.1172\/jci.insight.142838","article-title":"Pdcd10-Stk24\/25 complex controls kidney water reabsorption by regulating Aqp2 membrane targeting.","volume":"6","author":"Lu","year":"2021","journal-title":"JCI Insight"},{"key":"53","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas.","volume":"17","author":"Dekkers","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"54","doi-asserted-by":"publisher","first-page":"E183","DOI":"10.1002\/ajh.24066","article-title":"Temozolomide induced bone marrow Suppression--A single institution outcome analysis and review of the literature.","volume":"9","author":"Patnaik","year":"2015","journal-title":"Am J Hematol"},{"key":"55","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/neuonc\/not036","article-title":"Secondary hematological malignancies associated with temozolomide in patients with glioma.","volume":"1","author":"Shibui","year":"2013","journal-title":"Neuro Oncol"},{"key":"56","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.","volume":"9","author":"Wass","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"57","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1210\/clinem\/dgaa649","article-title":"Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor.","volume":"10","author":"Geer","year":"2020","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T15:48:04Z","timestamp":1661183284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":57,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2022,8,15]]}},"alternative-id":["204206","35963638"],"URL":"https:\/\/doi.org\/10.18632\/aging.204206","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]}}}